Has ‘scaremongering’ about the Oxford jab undermined EU’s vaccination campaign?

People in Germany and France are refusing to be inoculated with the UK-developed vaccine

Emmanuel Macron gestures as he speaks during a video conference meeting.
(Image credit: Gonzalo Fuentes/Pool/AFP via Getty Images)

Contradictory claims about the effectiveness of the Oxford-AstraZeneca vaccine are hindering the rollout of Covid-19 jabs in Germany and several other European nations, latest uptake figures suggest.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

  Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.